Echocardiography in hypertension: A call for standardization from the Working Group on Heart and Hypertension of the Italian Society of Hypertension

High Blood Pressure and Cardiovascular Prevention

Volumn 21, Issue 1, 2014, Pages 53-61

  Cuspidi, Cesare ^a   Muiesan, Maria Lorenza ^b   De Luca, Nicola ^c   Salvetti, Massimo ^b   Agabiti Rosei, Enrico ^b   Schillaci, Giuseppe ^d  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Diagnostic quality; Echocardiography; Hypertension; Standardization

Indexed keywords

AORTA ROOT; ARTICLE; ASCENDING AORTA; CARDIOVASCULAR RISK; CLINICAL PRACTICE; ECHOCARDIOGRAPHY; GEOMETRY; HEART LEFT ATRIUM; HEART LEFT VENTRICLE HYPERTROPHY; HEART SIZE; HUMAN; HYPERTENSION; ITALY; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MEDICAL SOCIETY; PRIORITY JOURNAL; STANDARDIZATION; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COMPARATIVE STUDY; COMPLICATION; COST BENEFIT ANALYSIS; ECHOGRAPHY; ECONOMICS; ELECTROCARDIOGRAPHY; HEART ATRIUM; HEART VENTRICLE; PATHOPHYSIOLOGY; PHYSIOLOGY; PRACTICE GUIDELINE; PROCEDURES; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STANDARDS;

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COST-BENEFIT ANALYSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART ATRIA; HEART VENTRICLES; HUMANS; HYPERTENSION; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 84898776303     PISSN: 11209879     EISSN: 11791985     Source Type: Journal    
DOI: 10.1007/s40292-013-0030-3     Document Type: Article

References (48)

1. Gottdiener JS. Hypertension: left ventricular hypertrophy, hypertensive heart disease, and the impact of echocardiographic data on treatment options, prognosis and assessment of therapy. In: Otto CM, editor. The practice of clinical echocardiography. Philadelphia: Saunders Company; 1997. p. 521-546.
2. Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J. 2001;141:334-41. (Pubitemid 32200259)
3. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, Vargiu P, Simongini I, Laragh JH. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol. 1992;19:1550-8.
4. Khouri MG, Peshock RM, Ayers CR, de Lemos JA, Drazner MH. A 4-tiered classification of left ventricular hypertrophy based on left ventricular geometry: the Dallas heart study. Circ Cardiovasc Imaging. 2010;3:164-71.
5. Ruilope LM, Schmieder RE. Left ventricular hypertrophy and clinical outcomes in hypertensive patients. Am J Hypertens. 2008;21:500-6.
6. Cuspidi C, Rescaldani M, Sala C. Prevalence of echocardiographic left atrial enlargement in hypertension: a systematic reviewof recent clinical studies. Am J Hypertens. 2013;26:456-64.
7. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report. JAMA 2003;289:2560-72.
8. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens. 2009;27:2121-56.
9. Agabiti-Rosei E, de Simone G, Mureddu GF, Trimarco B, Verdecchia P, Volpe M. Arterial hypertension and cardiac damage: diagnostic and therapeutic guidelines. High Blood Press Cardiovasc Prev. 2008;15:141-69.
10. Evangelista A, Flachskampf F, Lancellotti P, Badano L, Aguilar R, Monagham M, et al. European Association of Echocardiography recommendations for standardization of performance, digital storage and reporting of echocardiographic studies. Eur J Echocardiogr. 2008;9:438-48. (Pubitemid 351882129)
11. Poppe KK, Doughty RN, Whalley GA. Redefining normal reference rages for echocardiography: a major new individual person data meta-analysis. Eur Heart J Cardiovasc Imaging. 2013;14:347-8.
12. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991;114:345-52.
13. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561-6. (Pubitemid 20176696)
14. Levy D, Salomon M, D'Agostino RB, Belanger AJ, Kannel WB. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation. 1994;90:1786-93. (Pubitemid 24320926)
15. Bombelli M, Facchetti R, Carugo S, Madotto M, Arenare F, Quarti-Trevano F, et al. Left ventricular hypertrophy increases cardiovascular risk independently of in- and out-of office blood pressure values. J Hypertens. 2009;27:2458-64.
16. Tsioufis C, Vezali E, Tsiachris D, Dimitriadis K, Taxiarchou E, Chatzis D, et al. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study. J Hypertens. 2009;27:744-52.
17. Barbieri A, Bursi F, Mantovani F, Valenti C, Quaglia M, Berti E, et al. Left ventricular hypertrophy reclassification and death: application of the Recommendation of the American Society of Echocardiography/European Association of Echocardiography. Eur Heart J Cardiovasc Imaging. 2012;13:109-17.
18. Bouzas-Mosquera A, Broullon FJ, Alvarez-Garcia N, Peteiro J, Mosquera VX, Castro-Beiras A. Association of left ventricular mass with all-cause mortality, myocardial infarction and stroke. PLOS ONE. 2012;7:e45570.
19. de Simone G, Izzo R, Chinali M, De MM, Casalnuovo G, Rozza F, Girfoglio D, Iovino GL, Trimarco B, De LN. Does information on systolic and diastolic function improve prediction of a cardiovascular event by left ventricular hypertrophy in arterial hypertension? Hypertension. 2010;56:99-104.
20. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450-8. (Pubitemid 16119719)
21. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. American Society of Echocardiography's Nomenclature and Standards Committee, Task Force on Chamber Quantification, American College of Cardiology Echocardiography Committee, American Heart Association, European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7:79-108.
22. de Simone G, Muiesan ML, Ganau A, Longhini C, Verdecchia P, Palmieri V, et al. Reliability and limitations of ecocardiographic measurement of left ventricular mass for risk stratification and follow-up in single patients: the RES trial. Working Group on Heart and Hypertension of the Italian Society of Hypertension. Reliability of M-mode Echocardiographic Studies. J Hypertens. 1999;17:1955-63. (Pubitemid 30345337)
23. Mor-Avi V, Sugeng L, Weinert L, MacEneaney P, Caiani EG, Koch R, Salgo IS, Lang RM. Fast measurement of left ventricular mass with real-time three-dimensional echocardiography: comparison with magnetic resonance imaging. Circulation. 2004;110:1814-8. (Pubitemid 39299223)
24. Schillaci G, Verdecchia P, Porcellati C, Cuccurullo O, Cosco C, Perticone F. Continuous relationship between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension. 2000;35:580-6. (Pubitemid 30108152)
25. Cuspidi C, Facchetti R, Sala C, Bombelli M, Negri F, Carugo S, et al. Normal values of left ventricular mass: echocardiographic findings of the PAMELA study. J Hypertens. 2012;30:997-1003.
26. Wild PS, Sinning CR, Roth A, Wilde S, Schnabel RB, Lubos E, et al. Distribution and categorization of left ventricular measurements in the general population. Results from the population-based Gutenberg heart study. Circ Cardiovasc Imaging. 2010;3:604-13.
27. de Simone G, Kizer JR, Chinali M, Roman MJ, Bella JN, Best LG, For the Strong Heart Study Investigators, et al. Normalization for body size and population attributable risk of left ventricular hypertrophy. Am J Hypertens. 2005;18:191-6. (Pubitemid 40332548)
28. Cuspidi C, Negri F, Giudici V, Muiesan ML, Grandi AM, Ganau A, et al. on behalf of the Working Group on Heart and Hypertension of the Italian Society of Hypertension. Self-reporting weight and height implications for left ventricular hypertrophy detection: an Italian multicenter study. Clin Exp Hypertens. 2011;33:192-201.
29. Muiesan ML, Salvetti M, Monteduro C, Bonzi B, Paini A, Viola S, et al. Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension. 2004;43:731-8. (Pubitemid 38405579)
30. Palmieri V, Wachtell K, Gerdts E, Bella JN, Papademetriou V, Tuxen C, et al. Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: the LIFE study. Am Heart J. 2001;141:784-91. (Pubitemid 32378488)
31. de Simone G, Palmieri V, Koren MJ, Mensah GA, Roman MJ, Devereux RB. Prognostic implications of the compensatory nature of left ventricular mass in arterial hypertension. J Hypertens. 2001;19:119-25. (Pubitemid 32099284)
32. Muiesan ML, Salvetti M, Paini A, Monteduro C, Galbassini G, Bonzi B, Poisa P, Belotti E, Agabiti Rosei C, Rizzoni D, Castellano M, Agabiti Rosei E. Inappropriate left ventricular mass changes during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension. 2007;49:1077-83. (Pubitemid 351664327)
33. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelista A. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr. 2009;10:165-93.
34. Klein AL, Burstow DJ, Tajik AJ, Zachariah PK, Bailey KR, Seward JB. Effects of age on left ventricular dimensions and filling dynamics in 117 normal persons. Mayo Clin Proc. 1994;69:212-24. (Pubitemid 24085952)
35. Sharp AS, Tapp RJ, Thom SA, Francis DP, Hughes AD, Stanton AV, et al. Tissue Doppler E/E′ ratio is a powerful predictor of primary cardiac events in a hypertensive population: an ASCOT sub-study. Eur Heart J. 2010;31:747-52.
36. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281-357.
37. Yeaboah J, Rodriguez CJ, Stacey B, Lima JA, Liu S, Carr JJ, et al. Prognosis of individuals with asymptomatic left ventricular systolic dysfunction in the multi-ethnic study of atherosclerosis (MESA). Circulation. 2012;126:2713-9.
38. De Simone G, Devereux RB. Midwall mechanics in hypertension. Eur J Echocardiogr. 2002;3:193-8.
39. Aurigemma GP, Silver KH, Priest MA, Gaasch WH. Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy. J Am Coll Cardiol. 1995;26:195-202.
40. Mondillo S, Galderisi M, Ballo P, Marino PN. Left ventricular systolic longitudinal function: comparison among simple M-Mode, pulsed, and M-mode color tissue doppler of mitral annulus in healthy individuals. J Am Soc Echocardiogr. 2006;19:1085-91. (Pubitemid 44301804)
41. Narayanan A, Aurigemma GP, Chinali M, Hill JC, Meyer TE, Tighe DA. Cardiac mechanics in mild hypertensive heart disease: a speckle-strain imaging study. Circ Cardiovasc Imaging. 2009;2:382-90.
42. Miyoshi H, Oishi Y, Mizuguchi Y, Iuchi A, Nagase N, Ara N, Oki T. Early predictors of alterations in left atrial structure and function related to left ventricular dysfunction in asymptomatic patients with hypertension. J Am Soc Hypertens. 2013;7:206-15.
43. Lester SJ, Ryan EW, Schiller NB, Foster E. Best method in clinical practice and in research studies to determine left atrial size. Am J Cardiol. 1999;84:829.
44. Tsang TS, Abhayaratna WP, Barnes ME, Miyasaka Y, Gersh BJ, Bailey KR, Cha SS, Seward JB. Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter? J Am Coll Cardiol. 2006;47:1018-23.
45. Evangelista A, Flachskampf FA, Erbel R, Antonini-Canterin F, Vlachopoulos C, Rocchi G, European Association of Echocardiography, et al. Echocardiography in aortic diseases: EAE recommendations for clinical practice. Eur J Echocardiogr. 2010;11(8):645-58.
46. Baguet JP, Chavanon O, Sessa C, Thony F, Lantelme P, Barone-Rochette G, Mallion JM. European Society of Hypertension scientific newsletter: hypertension and aortic diseases. J Hypertens. 2012;30:440-3.
47. Devereux RB, de Simone G, Arnett DK, Best LG, Boerwinkle E, Howard BV, et al. Normal limits in relation to age, body size and gender of two-dimensional echocardiographic aortic root dimensions in persons ≥15 years of age. Am J Cardiol. 2012;110:1189-94.
48. Milan A, Avenatti E, Tosello F, Iannaccone A, Leone D, Magnino C, Veglio F. Aortic root dilatation in essential hypertension: prevalence according to new reference values. J Hypertens. 2013;31:1189-95.